MUGARD Trademark

Trademark Overview


On Thursday, August 26, 2010, a trademark application was filed for MUGARD with the United States Patent and Trademark Office. The USPTO has given the MUGARD trademark a serial number of 85116721. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by Access Pharmaceuticals. The MUGARD trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; ] Pharmaceutical preparations for the treatment and prevention of oral [ and esophageal ] mucositis [ ; drug delivery agents consisting of compounds that facilitate delivery of a wide range of active pharmaceuticals to the oral mucosa ]
mugard

General Information


Serial Number85116721
Word MarkMUGARD
Filing DateThursday, August 26, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number3950832
Registration DateTuesday, April 26, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 8, 2011

Trademark Statements


Goods and Services[ Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; ] Pharmaceutical preparations for the treatment and prevention of oral [ and esophageal ] mucositis [ ; drug delivery agents consisting of compounds that facilitate delivery of a wide range of active pharmaceuticals to the oral mucosa ]
Pseudo MarkMUCOADHESIVE GARD; MUCOADHESIVE GUARD

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateMonday, December 25, 2006
First Use In Commerce DateMonday, December 25, 2006

Trademark Owner History


Party NameAMAG PHARMACEUTICALS, INC.
Party Type33 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressWALTHAM, MA 02451

Party NameABEONA THERAPEUTICS INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDALLAS, TX 75219

Party NamePLASMATECH BIOPHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDALLAS, TX 75219

Party NameAccess Pharmaceuticals
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDallas, TX 75207

Party NameAccess Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75207

Party NameAccess Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75207

Trademark Events


Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, February 24, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 10, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sunday, April 26, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 22, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 19, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, December 19, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, December 19, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, October 10, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 26, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 8, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 26, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 26, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 26, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, February 8, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 8, 2011PUBLISHED FOR OPPOSITION
Thursday, January 6, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, January 6, 2011ASSIGNED TO LIE
Thursday, December 9, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 9, 2010EXAMINER'S AMENDMENT ENTERED
Thursday, December 9, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 9, 2010EXAMINERS AMENDMENT E-MAILED
Thursday, December 9, 2010EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 8, 2010ASSIGNED TO EXAMINER
Tuesday, August 31, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 30, 2010NEW APPLICATION ENTERED IN TRAM